AOD 9604 Peptide

AOD 9604 Peptide is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly associated with the amino acid sequence corresponding to hGH fragment 176–191. It was developed to explore the lipid-metabolism-related activity of growth hormone fragments while aiming to avoid the broader growth-promoting effects typically linked with full-length human growth hormone.

In research settings, AOD 9604 is mainly studied for its potential influence on lipolysis, fat metabolism, adipocyte function, and metabolic regulation. Unlike complete human growth hormone, AOD 9604 is not designed to act as a general growth-promoting hormone. Its value lies in its focused research profile as a short peptide associated with fat metabolism and obesity-related biological pathways.

Shaanxi Medibridge Biotech Co., Ltd. supplies this material as research-grade powder or customized vial filling. Each batch can be supported with HPLC purity data, LC-MS identity testing, COA, and agreed packaging details. The product is supplied for research use only.

Preclinical and early human studies suggest possible activity in:

• Increasing lipolysis (fat breakdown)
• Reducing lipogenesis (fat formation)
• Enhancing fat oxidation

A 2008 study published in the Journal of Endocrinology found that GH fragment 176-191 increased lipid oxidation in test systems and did not stimulate IGF-1 or GH signaling like full GH.

Some exploratory research also evaluated potential roles in cartilage repair and tissue healing, such as a small study cited by Metabolic Pharmaceuticals evaluating joint repair models, but human clinical evidence remains limited.

Some reports and animal studies suggest AOD 9604 may:

• Support fat metabolism and oxidation
• Influence lipolysis pathways in adipose tissue
• Reduce body-fat accumulation in rodent models

A randomized trial published in Regulatory Toxicology and Pharmacology, found AOD 9604 showed good short-term tolerability and did not significantly change glucose or IGF-1 levels.

• Focused Research Profile

AOD 9604 has a specific research identity related to lipid metabolism and adipocyte biology. This focused profile makes it useful for studies where researchers want to examine fat-metabolism-related peptide activity without using full-length growth hormone.

• Synthetic and Defined Peptide

As a synthetic peptide, AOD 9604 can be manufactured with controlled sequence identity and purity. This provides advantages over complex biological extracts where composition may vary more significantly between batches.

• Useful for Mechanistic Studies

AOD 9604 can help researchers explore pathways involved in lipolysis, lipogenesis, adipocyte differentiation, and metabolic regulation. It is especially relevant in studies that examine the relationship between peptide signaling and fat cell function.

• Suitable for Analytical Characterization

Its peptide nature allows quality evaluation by established analytical methods such as HPLC and mass spectrometry. This supports identity confirmation, purity assessment, and batch consistency testing.

• Potential Formulation Value

AOD 9604 may be useful in peptide formulation research, especially where stability, solubility, and delivery behavior are being studied.

What Does Research Suggest About Fat Loss Potential?

The most favorable human signal came from earlier Phase II work summarized in reviews, including a 12-week trial in which 1 mg/day was reported to produce greater mean weight loss than placebo. FDA reviewers emphasized that these early data were available only in limited summaries or abstracts and that the larger 24-week trial failed to show significant benefit versus placebo. The clinical evidence does not support a guaranteed fat loss claim.

Targeted Fat Metabolism Versus Target Fat and Stubborn Fat Claims

AOD-9604 is sometimes described online as targeting fat cells or stubborn fat, but published evidence does not establish selective regional fat loss in patients. Preclinical work involved adipose tissue and lipid metabolism, while human trials mainly assessed body weight and related endpoints. A safer framing is "targeted fat metabolism has been hypothesized," not "AOD-9604 targets stubborn fat."

• Obesity and Fat Metabolism Research

AOD 9604 is most commonly associated with obesity-related research. It is used to investigate how peptide fragments may influence lipid breakdown, fat storage, and adipose tissue activity.

• Adipocyte Biology

AOD 9604 is useful in studies involving fat cell function. It may be applied in cell-based models to explore how adipocytes respond to peptide exposure under different metabolic conditions.

• Drug Development and Screening

AOD 9604 may serve as a reference compound or candidate peptide in drug discovery programs focused on metabolic modulation. Researchers may use it to compare peptide fragments, evaluate delivery systems, or study peptide stability.

• Formulation Research

Due to its peptide structure, AOD 9604 can be used in formulation studies involving peptide solubility, stability, delivery, and preservation. Researchers may evaluate how different buffers, excipients, temperatures, and storage conditions affect its quality and performance.